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Background: Trial registration and the reporting of trial results are essential to increase transparency in clinical
research. Although both have been strongly promoted in recent years, it remains unclear whether they have been
successfully implemented in surgery and surgery-related disciplines. In this cross-sectional study, we assessed
whether randomized controlled trials (RCTs) published in surgery journals requiring trial registration in their author
instructions were indeed registered, and whether the study results of registered RCTs had been submitted to the
trial register and were thus publicly available.
Methods: The ten highest ranked surgery journals requiring trial registration by impact factor (Journal Citation
Reports, JCR, 2011) were chosen. We then searched MEDLINE (in PubMed) for RCTs published in the selected
journals between 1 June 2012 and 31 December 2012. Any trials recruiting participants before 2004 were excluded
because the International Committee of Medical Journal Editors (ICMJE) first proposed trial registration in 2004. We
then searched the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) to assess
whether the identified RCTs were indeed registered and whether the results of the registered RCTs were available
in the register.
Results: The search retrieved 588 citations. Four hundred and sixty references were excluded in the first screening. A
further 25 were excluded after full-text screening. A total of 103 RCTs were finally included. Eighty-five of these RCTs
(83%) could be found via the ICTRP. For 7 of 59 (12%) RCTs, which were registered on ClinicalTrials.gov, summary study
data had been posted in the results database.
Conclusions: Although still not fully implemented, trial registration in surgery has gained momentum. In general,
however, the submission of summary study data to ClinicalTrials.gov remains poor.
Keywords: Trial registration, Randomized controlled trials, Surgery journals, Results reportingBackground
Selective reporting of study results distorts the body of
evidence available for clinical decision making. In recent
years, several guidelines and recommendations have
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reproduction in any medium, provided the ordevelopment towards more transparency was the call for
the obligatory registration of all clinical trials in public
trial registers. In September 2004, the International Com-
mittee of Medical Journal Editors (ICMJE) proposed ‘com-
prehensive trial registration as a solution to the problem
of selective awareness’. In order to advance this goal, the
ICMJE decided to require the registration in a public trials
register as a mandatory condition for the consideration
for the publication of a study report. The ICMJE trial
registration requirement policy applies to all trials which
started patient recruitment beginning 1 July 2005, and wastd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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many other journals in addition to the ICMJE member
journals have adopted the ICMJE policy.
The implementation of comprehensive mandatory trial
registration would allow scientists, clinicians, and study
participants to track trials and prevent biased reporting,
for example the non-reporting of trials with negative or
inconclusive results. Therefore, even unfavorable trial re-
sults would not be lost to the pool of medical know-
ledge. Based on the information provided by the register,
prospective investigators would be able to formulate
new research questions, plan new trials to fill the gaps in
the knowledge base, and avoid unnecessary duplications
[2]. Furthermore, public electronic access to all trials
could inspire researchers to collaborate and could also
support trial recruitment [3].
In April 2007, the ICMJE expanded the definition of clin-
ical trials that have to be registered by adopting the World
Health Organization (WHO) definition of a clinical trial,
which also includes preliminary trials (phase I trials). The
deadline for the implementation of these modifications was
1 July 2008 [4]. One month after the ICMJE’s expansion of
the definition, in May 2007, the WHO launched its Inter-
national Clinical Trials Register Platform (ICTRP) in order
to offer an international portal for identifying, deduplicat-
ing, and searching trials from registers all over the world.
The ICTRP requires a minimum trial registration data set
consisting of 20 items [2], which is also supported by the
ICMJE [5]. As of 1 July 2007, the member journals of the
Surgery Journal Editors Group (SJEG) require registration
of all prospective clinical trials prior to the enrollment of
the first patient [6]. Trials which had started recruitment
before the deadline had to register before editorial review.
Manuscripts are now required to specify the registration
number in the abstract [7].
But how did all these policy recommendations, regula-
tions, and statements influence the practice of trial regis-
tration? By examining the development and growth of
ClinicalTrials.gov, the largest public trial register, which
was created as a result of the Food and Drug Administra-
tion Modernization Act (FDAMA) in 1997, it can be con-
cluded that trial registration has gained momentum and
that there has been major progress within the last decade.
As of 13 November 2013, ClinicalTrials.gov included
more than 154,000 studies from across all 50 American
states and 185 countries worldwide (http://www.clinical-
trials.gov/ct2/resources/trends).
In September 2008, the ClinicalTrials.gov results data-
base was launched to meet the requirement in Section
801 of the Food and Drug Administration Amendments
Act (FDAAA 801) that study sponsors or principal in-
vestigators report basic results for ‘applicable clinical tri-
als’ (ACTs). A trial is considered ‘applicable’ if it meets
the following criteria: phase II to IV interventional studyinvolving drugs or medical devices regulated by the
FDA; at least one site in the USA; and initiated or on-
going as of 27 September 2007, or later [8]. For all ap-
plicable trials, the results have to be submitted no later
than 12 months after the trial’s completion date (http://
www.clinicaltrials.gov/ct2/manage-recs/fdaaa - WhenDo
INeedToRegister). The summary results data in the results
database are presented mainly in a tabular format and are
publicly accessible. This does not only benefit researchers
and journal editors but also patients and the general pub-
lic. The main objectives of the ClinicalTrials.gov results
database are to reduce publication bias and selective out-
come reporting and to promote complete reporting by
structured data entry [9].
Although the facts and numbers presented above indi-
cate a remarkable success of the initiatives and efforts to
promote trial registration and results reporting, it remains
unclear whether these have been successfully imple-
mented as integral parts of clinical research in surgery and
surgery-related disciplines. We therefore chose to explore
whether randomized controlled trials (RCTs) published in
the ten highest ranked (by impact factor) surgery journals
that require trial registration in their author instructions
were indeed registered. We also chose to address the
question of whether the study results of the registered
RCTs were publicly available on the trial register website.
Methods
We accessed the Journal Citation Reports (JCR) Science
Edition 2011 on 8 January 2013. Two authors (JH and
MIM) independently identified the first ten journals
among the top surgery journals by impact factor that re-
quired trial registration in the author instructions on
their websites (Table 1). All journals not explicitly re-
quiring trial registration in their author instructions
were excluded. We intentionally chose the ten journals
with the highest impact factors assuming that their pol-
icies and publishing practices would meet the current
highest standards. Moreover, we expected that trialists
publishing in such top-class journals would be more
likely to act in an exemplary manner with regard to trial
registration and results reporting.
The American Journal of Surgical Pathology (impact
factor 4.352) and Annals of Surgical Oncology (impact
factor 4.166) were excluded because the author instruc-
tions of these journals did not require trial registration.
JCR, Journal Citation Reports.
In a second step, MEDLINE was searched via PubMed
for RCTs published in these journals between 1 June 2012
and 31 December 2012. All of the included journals are
fully indexed in the MEDLINE database. For the identifica-
tion of RCTs in MEDLINE (search conducted 15 February
2013), we applied the sensitivity-maximizing Cochrane
Highly Sensitive Search Strategy for identifying RCTs in
Table 1 The first ten journals among the top surgery
journals by impact factor that required trial registration
in the author instructions
Journal Country Impact factor
(JCR 2011)
Annals of Surgery USA 7.492
American Journal of Transplantation USA 6.394
Endoscopy Germany 5.210
Journal of Neurology, Neurosurgery
& Psychiatry
UK 4.764
British Journal of Surgery UK 4.606
Journal of the American College of Surgeons USA 4.549
Archives of Surgery (JAMA Surgery
since 1 January 2013)
USA 4.422
Surgical Endoscopy Germany 4.013
Transplantation USA 4.003
Surgery for Obesity and Related Diseases USA 3.929
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modified to fit the surgical setting (Additional file 1).
One author (JH) screened titles and abstracts, excluded
clearly irrelevant references, and downloaded full-texts of
all potentially relevant citations. Then, two authors (JH
and MIM) independently screened the full-texts and ex-
cluded non-randomized studies. Trials recruiting partici-
pants prior to 2004 were also excluded because the ICMJE
first proposed comprehensive trial registration in a state-
ment published in September 2004, which requires regis-
tration in a public trials register for trials that started
enrollment after 1 July 2005 only. All discrepancies were
resolved by re-examining the full-texts and in discussion
with a third author (JM).
In the next step, two authors (JH and MIM) independ-
ently searched the ICTRP (27 February 2013) for infor-
mation on the registration of all included RCTs. Trials
were searched for either with the registration identifica-
tion quoted in the publication or, if this identification
was not provided, with different keywords describing the
topic of the trial. We searched using the ICTRP’s stand-
ard search form, which searches within the title, primary
sponsor, health condition(s), intervention(s), countries of
recruitment, main identification, and secondary identifi-
cation(s) of the trial data. Additionally, we used Boolean
operators to broaden or narrow the search. If such a
search was not successful, we took a more sensitive ap-
proach by searching first for the main author’s name,
second for the most specific terms of the institutional
name stated in the authors’ affiliations, or third for the
country or city the trial was conducted in combined with
one or two specific terms describing the trial. Trials not
found through these extensive ICTRP searches were
considered to be unregistered.Reviewing the full-texts and the information given on the
trials register website, we collected data regarding the fol-
lowing topics and parameters: sample size, country of main
investigator, national versus multinational and monocenter
versus multicenter setting, surgical subspecialty, study ob-
jective, and start of patient recruitment. Furthermore, we
extracted information on whether trial registration was ex-
plicitly mentioned in the article, meaning whether the art-
icle included at least one full sentence describing that the
trial was registered in a specific trial register. We also
reviewed whether the registration number was specified in
the title, abstract, or main text, since the SJEG member
journals as well as the ICMJE demand specifications of the
trial registration number in the abstract as evidence of
registration [7]. Moreover, the ICMJE even recommends
that authors list the trial registration number the first time
a trial acronym is used in the manuscript (http://www.
icmje.org/publishing_10register.html).
Finally, the primary trial registers were checked for
study results of the registered RCTs. We defined study
results as either a citation to a publication reporting the
trial or, in the case that ClinicalTrials.gov was the pri-
mary register, if aggregate summary data were provided
in addition to a citation. Two authors (JH and MIM) ex-
tracted the following information for the registered
RCTs: primary register; link to a PubMed citation or list
of publication(s) provided by the investigators; and, if
ClinicalTrials.gov was the primary register: aggregate
summary study data posted in the ClinicalTrials.gov re-
sults database; automatic link to a PubMed citation
mapped via the ClinicalTrials.gov identifier (NCT num-
ber); and study start date and study registration date
(‘study first received’ in ClinicalTrials.gov) in order to
identify whether trials were registered retrospectively or
prospectively.
We did not explicitly assess if the RCTs registered in
ClinicalTrials.gov were ACTs according to the FDAAA
801. Ethics approval was not required for this study.
Results
There were 199 journals in the subject category ‘surgery’
indexed in JCR 2011. The first ten surgery journals with
the highest impact factors ranging from 7.492 to 3.929,
which explicitly required trial registration in their online
author instructions, were chosen (Table 1).
The search for RCTs published between 1 June 2012
and 31 December 2012 retrieved 588 citations. From
these, 460 clearly irrelevant references were excluded by
title or abstract screening. We then evaluated the full-
texts of the remaining 128 references (Additional file 2)
and excluded 25 of these for the following reasons: 21
studies had started patient recruitment prior to 2004,
two citations reported sub-studies of older RCTs, one re-
ported a non-randomized trial, and one was a study not
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(http://www.who.int/ictrp/en/). This last study had inves-
tigated whether there were any differences in the learning
outcomes of healthy participants who had trained to
proficiency on low- or high-fidelity laparoscopic surgical
simulators. The remaining 103 citations were further in-
vestigated. The majority of the RCTs (n = 86; 83%) had
initiated patient recruitment during or after 2006, 15
RCTs (15%) had started to recruit participants in 2004
or 2005, and two RCTs (2%) did not state the start of re-
cruitment (Figure 1).
Trial registration
Eighty-five of the 103 analyzed RCTs (83%) could be iden-
tified in the ICTRP (Table 2; Additional file 3). Of these
85 RCTs, 15 (18%) had been registered prospectively, 45
(53%) had been registered retrospectively, and 21 (25%)
had been registered within the same month as the study
start date. For the remaining four studies, we were not
able to find information on the study start and registration
dates for the following reasons: three of the RCTs were
only registered in the European Union Clinical Trials
Register (EU-CTR), which does not provide the date of
study registration, and one RCT was registered in a
Belgian register, which is publicly not accessible. All
RCTs that were prospectively registered had enrolled





































Figure 1 Study flow diagram: selection process of RCTs. RCT, randomizwhich started patient recruitment in 2004 or 2005 had
been registered prospectively (Table 2).
Seventeen (81%) of the 21 excluded RCTs with patient
recruitment before 2004 had been registered. All of them
had been retrospectively registered after enrollment of
the first patient.
Sixty-eight (80%) of the 85 registered trials specified the
registration identifier: 25 in the main text only, 21 in the
abstract and main text, ten in the abstract only, two in
the title and main text, one in the acknowledgments sec-
tion, and nine below or above the list of author affiliations
(two of them additionally specified the identifier in the
main text and abstract, respectively). The 17 (20%) regis-
tered trials without specification of the registration num-
ber were not classified as ‘registered’ unless they were
found in the ICTRP searching with words extracted from
the publication. One RCT which specified the registration
number in the abstract and main text reported the wrong
number twice. The reported number actually belonged to
another RCT of the same first author, and we discovered
the correct NCT identifier by searching the ICTRP. More-
over, we found four registered RCTs which were catego-
rized as a prospective cohort study (n = 3) or prospective
case–control study (n = 1).
Forty-four of the 68 (65%) RCTs specifying the regis-
tration number also mentioned trial registration expli-
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Table 2 Registration of RCTs stratified by start of patient recruitment
Start of patient recruitment
All 2004 to 2005 During or after 2006 Unclear
n = 103 (100%) n = 15 (100%) n = 86 (100%) n = 2 (100%)
Registered RCTs 85 (83%) 14 (93%) 71 (83%) 0
Registration (number) mentioned in article 68 (80.0%) 11 (71.4%) 57 (70.4%)
Registration (number) not mentioned in article 17 (20.0%) 3 (21.4%) 14 (19.7%)
Registered prospectively 15 (17.6%) 0 15 (21.1%)
Registered retrospectively 45 (52.9%) 12 (85.7%) 33 (46.5%)
Study start and registration within same month 21 (24.7%) 1 (7.1%) 20 (28.2%)
Unclear time relation between study start and registration 4 (4.7%) 1 (7.1%) 3 (4.2%)
Not registered 18 (17%) 1 (7%) 15 (17%) 2 (100%)
RCT, randomized controlled trial.
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report trial registration nor could they be found in the
ICTRP. Upon examination of the unregistered RCTs, we
noted the following differences to the registered RCTs:
all these RCTs were national and all had been under-
taken in a single-center setting, except for three RCTs
conducted at two to three centers. In addition, it seemed
that the median sample size was smaller (66 versus 126;
Table 3).
Reporting results
Sixty-one of the 85 registered RCTs were registered on
ClinicalTrials.gov. One of these RCTs was still ongoing
and published as a study protocol only, another one had
been withdrawn before enrollment of the first patient.
Both were excluded from further analysis, and the
remaining 59 RCTs were included. For 7 (12%) of them,Table 3 Study characteristics of the included RCTs
Study characteristic Registered RCTs (n = 85)
National,
multinational setting
68 (80%), 17 (20%)
Monocenter,
multicenter setting
49 (58%), 36 (42%)
Sample size
(median (range))
126 (12 to 66,000)
Country of
main investigator
USA (n = 13), Germany (n = 8), Netherlands (n = 7), Ch
(n = 6), Italy (n = 6), Norway (n = 6), UK (n = 5), Japan (
Austria (n = 3), Belgium (n = 3), Denmark (n = 3), South
(n = 3), Spain (n = 3), Sweden (n = 3), Switzerland (n =
Finland (n = 2), Egypt (n = 2), New Zealand (n = 2), an




General surgery (n = 24), endoscopy/gastroenterology
gastrointestinal surgery (n = 14), nephrology/kidney
transplantation/surgery (n = 10), bariatric surgery (n =
hepatology/liver transplantation/hepatobiliary surgery
anesthesiology/surgery (n = 5), pediatrics/pediatric su
(n = 3), psychiatry/neurology/surgery (n = 5), cardiolog
transplantation/cardiothoracic surgery (n = 2), colorec
surgery (n = 2), and other (n = 8)
RCT, randomized control trial.results had been posted in the results database (Table 4).
In our sample, the proportion of RCTs with summary
data posted on ClinicalTrials.gov was smaller among the
retrospectively registered trials in comparison to RCTs
with prospective registration (3/45 (7%) versus 3/15
(20%); relative risk 0.33; 95% confidence interval 0.08,
1.48; P = 0.15).
As mentioned in the Methods section, we did not ex-
plicitly assess whether the RCTs registered in Clinical-
Trials.gov were ACTs according to the FDAAA 801.
However, there are several reasons to assume that most
of the included RCTs were not ACTs. First, not all of
them had at least one site in the USA and were initiated
or ongoing as of 27 September 2007, or later. Second,
several included RCTs compared surgical procedures in-
stead of drug or device interventions. Thus, we presume
that most of the analyzed trials were not required toUnregistered RCTs (n = 18)
18 (100%), 0
15 (83%), 3 (17%)






South Korea (n = 5), USA (n = 5), Brazil (n = 2), UK (n = 2),







General surgery (n = 9), gastroenterology/gastrointestinal
endoscopy/gastrointestinal surgery (n = 3), anesthesiology (n = 2),
neurosciences/neurology/psychiatry/otolaryngology (n = 2),
pediatric surgery (n = 1), and reconstructive breast surgery (n = 1)
Table 4 Results availability for registered RCTs stratified by completion date
Study completion date
All Before or during
February 2011















Results posted 7 (12%) 5 (21%) 2 (8%) 0 0
Results posted only 2 (3%) 1 (4%) 1 (4%) 0 0
Results posted and link to publication provided by
investigator
1 (2%) 0 1 (4%) 0 0
Results posted and automatic linkage via register
identification
4 (7%) 4 (17%) 0 0 0
No results posted 52 (88%) 19 (79%) 23 (92%) 5 (100%) 5 (100%)
Link to publication provided by investigator only 1 (2%) 0 1 (4%) 0 0
Link to publication provided by investigator and automatic
linkage via register identification
1 (2%) 0 1 (4%) 0 0
Automatic linkage via register identification only 27 (46%) 9 (38%) 15 (60%) 1 (20%) 2 (40%)
No results posted and no link provided 23 (39%) 10 (42%) 6 (24%) 4 (80%) 3 (60%)
List of registries included in the ICTRP search portal (September 2013): Australian New Zealand Clinical Trials Registry (ANZCTR); ClinicalTrials.gov; European Union
Clinical Trials Register (EU-CTR); International Standard Randomised Controlled Trial Number Register (ISRCTN); Brazilian Clinical Trials Registry (ReBec); Chinese
Clinical Trial Registry (ChiCTR); Clinical Trials Registry - India (CTRI); Clinical Research Information Service (CRiS), Republic of Korea; Cuban Public Registry of Clinical
Trials (RPCEC); German Clinical Trials Register (DRKS); Iranian Registry of Clinical Trials (IRCT); Japan Primary Registries Network (JPRN); Pan African Clinical Trial
Registry (PACTR); Sri Lanka Clinical Trials Registry (SLCTR); and The Netherlands National Trial Register (NTR). ICTRP, International Clinical Trials Register Platform;
RCT, randomized controlled trial.
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the FDAAA 801.
Twenty-five RCTs had been registered in trial registers
other than ClinicalTrials.gov: International Standard Ran-
domised Controlled Trial Number Register (ISRCTN; n =
7), EU-CTR (n = 4), The Netherlands National Trial Regis-
ter (NTR; n = 3), Australian New Zealand Clinical Trials
Registry (ANZCTR; n = 2), German Clinical Trials Regis-
ter (DRKS; n = 2), Japan Primary Registries Network
University Hospital Medical Information Network (JPRN-
UMIN; n = 4), Belgian register (n = 1), Chinese Clinical
Trial Registry (ChiCTR; n = 1), and Clinical Trials Registry -
India (CTRI; n = 1). Of these registers, DRKS, ISRCTN,
CTRI, ANZCTR, NTR, and JPRN-UMIN provide a data
field for a link to publications on the study record page.
The study record page of only 5 (26%) of the 19 RCTs pri-
marily registered in these registers included a link to
PubMed citations or a list of publications. EU-CTR and
ChiCTR did not provide a data field for links to publica-
tions, and the Belgian register is not publicly accessible.
Discussion
Eighty-five of the 103 analyzed RCTs (83%) were regis-
tered and 80% (68/85) of the registered trials specified
the registration identifier, for example the NCT number,
in the study report. In addition, 65% (44/68) of RCTs
specifying the registration number also mentioned trial
registration explicitly in a full sentence in the abstract
and/or main text. Though the ICMJE trial registrationpolicy requires trial registration before the enrollment of
the first patient, only 18% of the registered trials had
been registered prospectively. The majority were regis-
tered retrospectively (53%) or within the same month as
the study start date (25%). This implies that with regard
to the vast majority of registered trials, it cannot be ex-
cluded that initial details of study design, objective, eligi-
bility criteria, or primary and secondary outcomes were
changed after study start. For this specific reason, retro-
spective registration is only suboptimal. On the other
hand, retrospective registration is helpful for the identifi-
cation of trials, especially those still ongoing or not yet
published.
The results of only 7 (12%) of the 59 RCTs registered on
ClinicalTrials.gov had been submitted to the Clinical-
Trials.gov results database. As mentioned before, we did
not assess whether these 59 RCTs were ACTs. Thus, it re-
mains unclear whether the legal requirements to submit
aggregate summary data to ClinicalTrials.gov really per-
tain to the included RCTs. Nonetheless, investigators of all
trials registered in ClinicalTrials.gov can voluntarily sub-
mit summary data to the results database. Though the
legal requirement to report results applies only to certain
interventional trials, sponsors and investigators should be
encouraged to use the results database for timely dissem-
ination of their research findings publicly [11].
For 28 (47%) of the trials registered on ClinicalTrials.
gov there was at least a link provided to publications,
which are automatically mapped to these studies by the
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cases there was no reporting of results or link to publi-
cations available at all.
Nguyen et al. recently published data on the public avail-
ability of trial results assessing cancer drugs in the USA.
They analyzed 646 trials (including 209 RCTs) regarding
results posting at ClinicalTrials.gov and/or publication of
results in journals. One year after the completion of the tri-
als, the results of only 9% of all trials (12% of the RCTs)
were available at ClinicalTrials.gov [12]. These data are
similar to our own results. Moreover, Nguyen et al. reports
that, despite the FDAAA, results of almost half of the trials
assessing cancer drugs were not publicly available (neither
at ClinicalTrials.gov nor in journals) three years after com-
pletion of the trials [12].
Jones et al. recently conducted a cross-sectional ana-
lysis of 585 trials with at least 500 participants, which
were prospectively registered with ClinicalTrials.gov to
estimate the frequency with which results of large RCTs
registered with ClinicalTrials.gov are not publicly avail-
able. Almost one third (n = 171) of the included 585
RCTs remained unpublished. Of the 171 unpublished
RCTs, almost 80% (n = 133) had no results available in
the ClinicalTrials.gov results database [13].
Comparing our findings regarding trial registration to
those from disciplines not related to surgery, it seems
that the awareness of the need for trial registration has
grown in the surgical research community. The pro-
portion of registered RCTs in this study by far exceeds
the reported numbers from other recent trials. Milette
et al. investigated the transparency of outcome reporting
and trial registration of RCTs published in top psycho-
somatic and behavioral health journals between January
2008 and September 2009 [14]. Of the 63 articles reviewed,
only 13 (20.6%) had been registered. A similar proportion
of registered trials were reported by McGee et al. who con-
ducted a cohort study of all RCTs in kidney transplantation
published between October 2005 and December 2010 and
determined trial registration and declaration of registration
by authors [15]. Of the 307 included trials, only 74 (24%)
had been registered; 44 (59%) of the registered trials de-
clared trial registration details at least within one study
report. Moreover, the authors investigated factors as-
sociated with trial registration. Trial registration was
more likely if the trial was published more than once, in
later years, or if it was reported in journals following the
ICMJE guidelines. Furthermore, trials conducted in the
USA were significantly more likely to be registered than
European trials. Trial registration was also less likely for tri-
als not declaring their funding source. Regarding the fac-
tors associated with declaration of registration details,
McGee et al. found that registered trials were more likely
to declare registration details in related reports if they
were published in a journal complying with the ICMJEguidelines or in later years (2007 to 2010). Compared to
European trials, trials conducted globally were less likely
to declare registration details. Interestingly, USA trials
were no more or even less likely to declare registration de-
tails than trials conducted in Europe.
Califf et al. recently examined the characteristics of
clinical trials (in three different medical specialties: car-
diovascular, mental health, oncology) registered in Clini-
calTrials.gov. Their analysis showed that the proportion
of prospectively registered trials increased over time
(from 33% in October 2004 to September 2007 to 48%
in October 2007 to September 2010) [16]. This is con-
cordant with our results (Table 2).
Reveiz et al. investigated another important aspect of
trial registration: its potential influence on reporting qual-
ity [17]. The authors conducted a cross-sectional study of
148 RCTs from the highest ranked journals (JCR 2006)
and analyzed this sample with regard to adherence to key
methodological items of the Consolidated Standards of
Reporting Trials (CONSORT) statement and several other
secondary outcomes, inter alia trial registration. Of these,
36% of the included RCTs reported trial registration.
Reporting quality was significantly better if trial registra-
tion was declared in the trial report.
Several studies have examined whether journals pub-
lishing original articles in specialties such as urology and
pediatrics endorse recommendations aimed at the im-
provement of publication practice. Meerpohl et al. ana-
lyzed the online author instructions of 69 journals indexed
in the subject category ‘pediatrics’ of JCR 2007 with regard
to endorsement of the Uniform Requirements for Manu-
scripts (URM) of the ICMJE, of five major reporting
guidelines, disclosure of conflicts, and trial registration
[18]. Only 16 (23%) of the included 69 journals either rec-
ommended or required trial registration. This means that
more than three quarters of pediatric journals did not re-
quire/recommend trial registration in August 2008. One
year later, Meerpohl et al. analyzed 41 pediatric open ac-
cess journals with regard to good publication practice
[19]. The authors came to the conclusion that pediatric
open access journals mention certain recommendations
and guidelines, for example the URM, more frequently
than conventional journals, but that the endorsement was
still only moderate. Trial registration, for example, was
only recommended/required by approximately a third
(32%) of the included journals.
Kunath et al. conducted a cross-sectional study of
RCTs published in 2009 in urology-related journals
indexed in JCR 2009 [20]. Of the 106 included RCTs,
63 (59.4%) were registered. The proportion of reports
of registered trials was significantly higher in journals re-
quiring trial registration as a requirement for publication
than in journals not mentioning trial registration in their
author instructions (71.4% versus 51.6%).
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to ensure good publication practice, especially complete
trial registration. Primarily, trialists are in charge of regis-
tering their trials. Reveiz et al. surveyed the corresponding
authors of a random sample of 500 clinical trials published
between May 2005 and May 2006 [21]. Of the 275 trialists
who completed the questionnaire, 64% supported the
registration of all 20 items of the WHO minimum data set
that should be recorded for clinical trial registration, while
6% did not support any of them. Only 21% of the respon-
dents had registered all of their trials since 2005. However,
47% declared the intention to provide all 20 items of the
WHO data set to a publicly accessible register for future
clinical trials. Comparing the respondents who received
mixed or only industry funding with those receiving only
non-industry funding, the latter were significantly more
likely to intend to provide all 20 WHO data set items for
future trials.
Looking into the future of trial registration and report-
ing, their successful implementation as integral parts of
clinical research highly depends on the continuous ef-
forts and initiatives taken by trialists, journal editors,
ethic boards, and funders.
There are some limitations to this study. We stu-
died a cohort of RCTs published between June 2012
and December 2012. Due to the moderate sample size, the
generalizability of the results might be limited. RCTs could
have been missed, because the PubMed search was per-
formed only 6 weeks after the evaluated time period.
Some citations might not yet have been fully indexed with
MeSH terms in MEDLINE. However, the Cochrane RCT
filter does not only use MeSH terms to identify RCTs, but
also text words within the database’s title/abstract field,
which have been validated for identifying RCTs. Thus, the
chance to have missed publications reporting an RCT not
yet indexed with MeSH terms is relatively low. It is also
possible that we erroneously declared a trial as unregis-
tered if it was registered within a register not included in
the ICTRP search platform and the registration was not
mentioned in the publication. In addition, since the ana-
lyzed cohort of RCTs was taken from the ten journals with
the highest impact factors (according to JCR 2011) which
explicitly required trial registration in their instructions to
authors, our results might overestimate the compliancy
with trial registration and therefore might not be transfer-
able to the entirety of surgery-related journals. This likely
implies a limited external validity of our results.
Conclusions
Although still suboptimal, the situation is improving over
time and trial registration is gaining momentum. How-
ever, complete prospective trial registration has not yet
been achieved even in top surgery journals, which expli-
citly require trial registration in their author instructions.Furthermore, the results reporting process, for example
the submission of study results to the ClinicalTrials.gov
results database, is still not widely practiced. Researchers,
peer reviewers, and journal editors should therefore con-
tinue to collaborate to improve trial reporting and
registration.
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